Meyka Pro banner
TNF Pharmaceuticals, Inc.

Stay Updated with the Latest TNF Pharmaceuticals, Inc. TNFA News in Real Time

Find TNFA news now at Meyka AI. Stay informed with the latest TNF Pharmaceuticals, Inc. stocks updates, including price news, market analysis, and expert insights.

TNFANASDAQ
HealthcareBiotechnology
$5.20
$1.69(48.15%)
U.S. Market opens in 15h 48m
Korean Stocks Tumble as SK Hynix Drops Almost 20%, AI Chip Rally Loses Steam
📅 3 hours ago

Korean Stocks Tumble as SK Hynix Drops Almost 20%, AI Chip Rally Loses Steam

On July 29, 2026, Korean stocks came under heavy selling pressure after SK Hynix shares fell nearly 20%, erasing a large part of this year’s AI-driven gains. The decline came despite the chipmaker reporting record revenue and a sharp rise in quarterly profit. Investors had expected even stronger results, and the market responded quickly. The…

Read more 12
USDA Issues Class I Recall of 12,036 Pounds of Maple Leaf Bacon on July 29
📅 7 hours ago

USDA Issues Class I Recall of 12,036 Pounds of Maple Leaf Bacon on July 29

USDA recalls 12,036 pounds of Maple Leaf Foods bacon imported from Canada for bypassing mandatory US import reinspection. Affected products sold in Idaho, Oregon, and Washington.

Read more 12
SK Hynix Quarterly Profit Jumps 557% but Falls Short of Market Expectations
📅 8 hours ago

SK Hynix Quarterly Profit Jumps 557% but Falls Short of Market Expectations

On July 29, 2026, SK Hynix reported a 557% increase in quarterly operating profit, helped by strong demand for high-bandwidth memory (HBM) chips used in artificial intelligence (AI) systems. The company also recorded its highest-ever quarterly revenue, reflecting continued growth in AI-driven memory demand. Even so, the results came in below market expectations, and the…

Read more 12
FDA Issues Class II Recall for Subpotent Levothyroxine Tablets on July 28
📅 1 day ago

FDA Issues Class II Recall for Subpotent Levothyroxine Tablets on July 28

Major Pharmaceuticals recalls levothyroxine sodium tablets nationwide due to subpotency. The FDA classified it as a Class II recall on July 17. Affected patients should consult their doctor and return medication to the pharmacy.

Read more 12
Vanguard Quietly Builds Nearly $1 Billion Strategy Stake Despite Bitcoin ETF Stance
📅 1 day ago

Vanguard Quietly Builds Nearly $1 Billion Strategy Stake Despite Bitcoin ETF Stance

Vanguard has increased its stake in Strategy Inc by $50 million, pushing its holding close to $1 billion. The asset manager now holds roughly 10.5 million shares of the Bitcoin treasury company. This comes despite Vanguard’s long-standing refusal to offer spot Bitcoin ETFs on its brokerage platform. The firm’s exposure stems from passive index tracking,…

Read more 12
Best High ROE Tech Stocks With Strong Growth Potential in 2026
📅 2 days ago

Best High ROE Tech Stocks With Strong Growth Potential in 2026

Return on Equity (ROE) is one of the first metrics many investors check when assessing technology stocks in 2026. With artificial intelligence, cloud computing, and semiconductor demand driving earnings, companies that generate strong returns from shareholder capital continue to attract attention.  In July 2026, several major tech firms reported solid profits even as they increased…

Read more 12
Trump Imposes 12.5% Tariff on Australian Exports From July 25
📅 5 days ago

Trump Imposes 12.5% Tariff on Australian Exports From July 25

Trump’s new 12.5% tariff on Australian exports takes effect July 25, replacing temporary 10% duty. Australia disputes forced labour claims and calls tariffs unjustified.

Read more 12
Generic Zyrtec Recalled Over Heartburn Drug Contamination July 24
📅 5 days ago

Generic Zyrtec Recalled Over Heartburn Drug Contamination July 24

Generic Zyrtec recalled nationwide due to contamination with heartburn drug ranitidine. Four lot numbers affected. No illnesses reported yet. Check your bottles.

Read more 12
Generic Zyrtec Recalled Over Heartburn Drug Mix-Up, July 23
📅 6 days ago

Generic Zyrtec Recalled Over Heartburn Drug Mix-Up, July 23

Generic Zyrtec recalled nationwide for cross-contamination with heartburn drug ranitidine. Four lot numbers affected. No illnesses reported yet. Call Rising Pharma at 1-844-874-7464.

Read more 12

TNFA News FAQ